Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain

By Konig P.   Beer M.   Makoschey B.   Teifke J.P.   Polster U.   Giesow K.   Keil G.M.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 202-212

Elsevier

Access to resources Recommend Favorite

Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12

By Von Beust B.R.   Brown W.C.   Estes D.M.   Zarlenga D.S.   McElwain T.F.   Palmer G.H.  

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 384-395

Elsevier

Access to resources Recommend Favorite

Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes

By Verger J.-M.   Grayon M.   Zundel E.   Lechopier P.   Olivier-Bernardin V.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice

By Naito M.   Matsuoka M.   Ohara N.   Nomaguchi H.   Yamada T.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 795-798

Elsevier

Access to resources Recommend Favorite

Mycobacterium avium subspecies paratuberculosis: the nature of the problem

By Hermon-Taylor J.  

Food Control, Vol. 12, Iss. 6, 2001-09 ,pp. : 331-334

Elsevier

Access to resources Recommend Favorite